Biofeedback, “exercise in a pill” and stress exposure are among the potential therapies to boost physical and mental fitness as we age.
New study provides evidence that a simple biofeedback practice reduces levels of Alzheimer’s-associated amyloid beta peptides.
The daily lives of people in the Indigenous Tsimané and Mosetén communities closely resemble those of pre-industrial societies and may provide clues for preventing heart disease and cognitive decline.
AI-powered analysis developed at USC accurately reflects risk of cognitive decline and Alzheimer’s disease based on brain age.
Increase in amyloid beta protein in the brain, often thought to be directly involved in Alzheimer’s pathology, may instead be a general change that occurs with age even in healthy brains, says senior author Caleb Finch.
Teal Eich, assistant professor of gerontology and psychology, recently received research funding from the National Institutes of Health and the Alzheimer’s Association for her investigation into the role of gamma-aminobutyric acid (GABA) in Alzheimer’s disease.
USC research led by Andrei Irimia shows how traumatic injuries increase the brain’s “biological age” and highlights the need for early monitoring.
Short cycles of a low-calorie diet that replicates fasting appeared to reduce inflammation and delay cognitive decline in mouse models of Alzheimer’s disease; initial data indicates diet’s safety in Alzheimer’s patients.
A mutation in the small protein SHMOOSE is associated with Alzheimer’s risk and highlights a possible target for treatment.
Researchers across USC have joined forces to uncover the connection between the air we breathe and lifelong brain health.